Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dannel Yeo

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|March 31, 2016
Glaucarubinone Combined with Gemcitabine Improves Pancreatic Cancer Survival in an Immunocompetent Orthotopic Murine ModelDannel Yeo, Nhi Huynh, John A Beutler, et al.
Pharmacological Research|June 30, 2022
Locoregional delivery of CAR-T cells in the clinicSharon M Sagnella, Amy L White, Dannel Yeo, et al.
Frontiers in Immunology|October 24, 2025
High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancerOliver Liang, Amy L White, Timothy Fielder, et al.
Cancer Letters|February 5, 2014
Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinasesDannel Yeo, Nhi Huynh, John A Beutler, et al.
Molecular Oncology|July 3, 2024
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patientsPrajwol Shrestha, Steven Kao, Veronica K Cheung, et al.
Histopathology|April 11, 2023
High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesotheliomaGerard J Chu, Anthony Linton, Steven Kao, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|August 21, 2013
Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinomaMehrdad Nikfarjam, Dannel Yeo, Hong He, et al.
Cytotherapy|February 13, 2024
Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicityGerard J Chu, Charles G Bailey, Rajini Nagarajah, et al.
Cellular and Molecular Life Sciences : CMLS|April 10, 2025
Portal venous circulating tumor cells as a biomarker for relapse prediction in resected pancreatic cancerDannel Yeo, Doruk Seyfi, Althea Bastian, et al.
Frontiers in Oncology|April 13, 2023
Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imagingDannel Yeo, Steven Kao, Ruta Gupta, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|March 31, 2016
Glaucarubinone Combined with Gemcitabine Improves Pancreatic Cancer Survival in an Immunocompetent Orthotopic Murine ModelDannel Yeo, Nhi Huynh, John A Beutler, et al.
Pharmacological Research|June 30, 2022
Locoregional delivery of CAR-T cells in the clinicSharon M Sagnella, Amy L White, Dannel Yeo, et al.
Frontiers in Immunology|October 24, 2025
High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancerOliver Liang, Amy L White, Timothy Fielder, et al.
Cancer Letters|February 5, 2014
Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinasesDannel Yeo, Nhi Huynh, John A Beutler, et al.
Molecular Oncology|July 3, 2024
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patientsPrajwol Shrestha, Steven Kao, Veronica K Cheung, et al.
Histopathology|April 11, 2023
High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesotheliomaGerard J Chu, Anthony Linton, Steven Kao, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|August 21, 2013
Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinomaMehrdad Nikfarjam, Dannel Yeo, Hong He, et al.
Cytotherapy|February 13, 2024
Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicityGerard J Chu, Charles G Bailey, Rajini Nagarajah, et al.
Cellular and Molecular Life Sciences : CMLS|April 10, 2025
Portal venous circulating tumor cells as a biomarker for relapse prediction in resected pancreatic cancerDannel Yeo, Doruk Seyfi, Althea Bastian, et al.
Frontiers in Oncology|April 13, 2023
Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imagingDannel Yeo, Steven Kao, Ruta Gupta, et al.
Pageof 3